Diphtheria clinical trials

Explore recruiting diphtheria clinical trials.

Recruiting diphtheria studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diphtheria trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

Italy, Poland, Finland, Netherlands, Greece, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

dTap booster vaccination of health care workers (HC dTap)

Finland

Therapeutic use (Phase IV) EU CTIS Study details

B7451031 - A Phase 3, Multicenter, Long-Term, Open-Label Study Evaluating the Safety and Efficacy of Abrocitinib, With or Without Topical Medications Administered to Pediatric Participants Aged 2 Years and Older With Moderate-to-Severe Atopic Dermatitis

Germany, Poland, Hungary, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

C1091009 - A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Finland, Netherlands, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase IV, Multicenter, Open-Label Study Evaluating B-Cell Levels in Infants Potentially Exposed to Ocrelizumab During Pregnancy – The MINORE Study

Spain, Germany

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled, parallel group study to assess the efficacy and long-term safety of dupilumab in children 2 to <6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze

Poland, Hungary, Czechia, Netherlands, Greece, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Diphtheria trials by city

Diphtheria in Toronto Diphtheria in Vancouver Diphtheria in Montreal Diphtheria in Calgary Diphtheria in Edmonton Diphtheria in Ottawa Diphtheria in Winnipeg Diphtheria in Quebec City Diphtheria in Hamilton Diphtheria in Kitchener Diphtheria in London Diphtheria in Halifax Diphtheria in New York Diphtheria in Los Angeles Diphtheria in Chicago Diphtheria in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease